SonoScape Medical Corp. (300633.SZ)
CNY 31.8
(-0.31%)
CNY 31.8
(-0.31%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 544.91 Million CNY | 21.58% |
| 2022 | 439.01 Million CNY | 19.37% |
| 2021 | 319.93 Million CNY | 75.94% |
| 2020 | 8.76 Million CNY | 29.49% |
| 2019 | 154.64 Million CNY | -42.28% |
| 2018 | 293.12 Million CNY | 31.32% |
| 2017 | 224.98 Million CNY | 38.02% |
| 2016 | 162.87 Million CNY | 23.93% |
| 2015 | 140.38 Million CNY | -15.77% |
| 2014 | 138.37 Million CNY | -10.19% |
| 2013 | 104.69 Million CNY | 43.98% |
| 2012 | 130.12 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 119.92 Million CNY | -22.53% |
| 2024 Q2 | 83.67 Million CNY | -40.68% |
| 2024 Q3 | -58.8 Million CNY | -188.22% |
| 2023 Q4 | 147.65 Million CNY | 103.13% |
| 2023 FY | - CNY | 21.58% |
| 2023 Q2 | 167.9 Million CNY | 8.55% |
| 2023 Q3 | 72.68 Million CNY | -56.71% |
| 2023 Q1 | 154.68 Million CNY | 8.95% |
| 2022 Q4 | 141.97 Million CNY | 48.97% |
| 2022 Q2 | 137.3 Million CNY | 88.33% |
| 2022 Q1 | 72.9 Million CNY | -64.7% |
| 2022 FY | - CNY | 19.37% |
| 2022 Q3 | 95.3 Million CNY | -30.59% |
| 2021 FY | - CNY | 75.94% |
| 2021 Q1 | 50.82 Million CNY | -66.09% |
| 2021 Q2 | 82.4 Million CNY | 62.12% |
| 2021 Q4 | 206.55 Million CNY | 689.43% |
| 2021 Q3 | 26.16 Million CNY | -68.25% |
| 2020 Q4 | 149.89 Million CNY | 4119.09% |
| 2020 Q3 | 3.55 Million CNY | -92.2% |
| 2020 Q2 | 45.53 Million CNY | 328.85% |
| 2020 Q1 | 10.61 Million CNY | -85.36% |
| 2020 FY | - CNY | 29.49% |
| 2019 FY | - CNY | -42.28% |
| 2019 Q4 | 72.55 Million CNY | 32529.32% |
| 2019 Q2 | 71.96 Million CNY | 372.86% |
| 2019 Q1 | 15.21 Million CNY | -83.83% |
| 2019 Q3 | -223.72 Thousand CNY | -100.31% |
| 2018 Q3 | 63.57 Million CNY | -37.59% |
| 2018 Q4 | 94.14 Million CNY | 48.07% |
| 2018 FY | - CNY | 31.32% |
| 2018 Q1 | 40.27 Million CNY | -60.99% |
| 2018 Q2 | 101.87 Million CNY | 152.95% |
| 2017 Q3 | 39.03 Million CNY | -49.87% |
| 2017 Q1 | 11.22 Million CNY | -92.16% |
| 2017 FY | - CNY | 38.02% |
| 2017 Q2 | 77.86 Million CNY | 593.62% |
| 2017 Q4 | 103.25 Million CNY | 164.53% |
| 2016 Q2 | 20.75 Million CNY | 301.88% |
| 2016 FY | - CNY | 23.93% |
| 2016 Q4 | 143.11 Million CNY | 732.23% |
| 2016 Q3 | 17.19 Million CNY | -17.13% |
| 2016 Q1 | -10.27 Million CNY | 0.0% |
| 2015 Q1 | 10.26 Million CNY | 0.0% |
| 2015 FY | - CNY | -15.77% |
| 2014 FY | - CNY | -10.19% |
| 2013 FY | - CNY | 43.98% |
| 2012 FY | - CNY | 0.0% |